Non–Small Cell Lung Cancer

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 228-228

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Gemcitabine and carboplatin in combination for the treatment of advanced, metastatic, non-small cell lung cancer

By Nagel Sylke   Califano Raffaele   Thatcher Nicholas   Blackhall Fiona  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 18, 2007-12 ,pp. : 3265-3275

Informa Healthcare

Access to resources Recommend Favorite

Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancer

By Vansteenkiste Johan   Canon Jean-Luc   Riska Henrik   Pirker Robert   Peterson Patrick   John William   Mali Pekka   Lahn Michael  

Investigational New Drugs, Vol. 23, Iss. 3, 2005-06 ,pp. : 263-269

Springer Publishing Company

Access to resources Recommend Favorite

Silencing of X-linked Inhibitor of Apoptosis Decreases Resistance to Cisplatin and Paclitaxel But Not Gemcitabine in Non-small Cell Lung Cancer

By Liu Y   Wu X   Sun Y   Chen F  

The Journal of International Medical Research, Vol. 39, Iss. 5, 2011-09 ,pp. : 1682-1692

Field House Publishing

Access to resources Recommend Favorite

Pharmacogenomics of gemcitabine in non-small-cell lung cancer and other solid tumors

By Danesi Romano   Altavilla Giuseppe   Giovannetti Elisa   Rosell Raffael  

Pharmacogenomics, Vol. 10, Iss. 1, 2009-01 ,pp. : 69-80

Future Medicine

Access to resources Recommend Favorite